Lenacapavir, the revolutionary HIV drug, still hasn’t reached Latin America
Global - South America
Archived
•
August 4, 2026
•
Countries such as Brazil, Mexico, or Peru — which took part in Gilead’s clinical trials — have not yet received doses and are pressing for the patent to be broken
Source: El País América | https://feeds.elpais.com/mrss-s/pages/ep/site/elpais.com/section/america/portada - Read Original
"5000+ Emails weekly."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Network Cable Repairs from $29"